Rioux, Nathalie
Epizyme (United States)
4 papers on CoChatORCID 0000-0003-2995-1734
Most cited papers
- Verified
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
Chan-Penebre, E., Kuplast, K. G., Majer, C. R., Boriack-Sjodin, P. A., Wigle, T. J., Johnston, L. D., Rioux, N., Munchhof, M. J., Jin, L., Jacques, S. L., et al. (2015) · Nature Chemical Biology
Cancer-related gene regulationProtein Degradation and Inhibitors
Cited by 569
- Verified
Preclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic-Site Integrase Inhibitor
Fenwick, C., Amad, M., Bailey, M. D., Bethell, R., Bös, M., Bonneau, P., Cordingley, M., Coulombe, R., Duan, J., Edwards, P., et al. (2014) · Antimicrobial Agents and Chemotherapy
HIV/AIDS drug development and treatmentHIV Research and Treatment
Cited by 99
- Verified
Novel Oxindole Sulfonamides and Sulfamides: EPZ031686, the First Orally Bioavailable Small Molecule SMYD3 Inhibitor
Mitchell, L. H., Boriack-Sjodin, P. A., Smith, S., Thomenius, M., Rioux, N., Munchhof, M., Mills, J. E., Klaus, C., Totman, J., Riera, T. V., et al. (2016) · ACS Medicinal Chemistry Letters
Cancer-related gene regulationEpigenetics and DNA Methylation
Cited by 91
- Verified
A high throughput in vitro mrp2 assay to predict in vivo biliary excretion
Colombo, F., Armstrong, C., Duan, J., & Rioux, N. (2012) · Xenobiotica
Drug Transport and Resistance MechanismsPharmacogenetics and Drug Metabolism
Cited by 16
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free